CLEVELAND BIOLABS INC·4

Mar 22, 4:43 PM ET

Fonstein Michael 4

4 · CLEVELAND BIOLABS INC · Filed Mar 22, 2011

Insider Transaction Report

Form 4
Period: 2011-03-21
Fonstein Michael
DirectorCEO, President
Transactions
  • Award

    Employee Stock Options (Right to Buy)

    2011-03-21+149,609149,609 total
    Exercise: $7.16From: 2011-03-21Exp: 2021-03-20Common Stock (149,609 underlying)
Holdings
  • Employee Stock Options (Right to Buy)

    Exercise: $3.44From: 2010-05-18Exp: 2020-05-17Common Stock (105,000 underlying)
    105,000
  • Employee Stock Options (Right to Buy)

    Exercise: $8.36From: 2007-04-06Exp: 2017-04-05Common Stock (37,500 underlying)
    37,500
  • Employee Stock Options (Right to Buy)

    Exercise: $4.00From: 2008-02-04Exp: 2018-02-03Common Stock (137,250 underlying)
    137,250
Footnotes (1)
  • [F1]On March 21, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Fonstein per the 2010 Executive Compensation Plan.

Documents

1 file
  • 4
    v215546_ex.xmlPrimary